Streetbeat News

Stock Prices

SP

SP Plus (NASDAQ:SP) reported Q4 2023 adjusted EPS of $0.60, missing the $0.85 estimate, and sales of $217.20M, below the $228.00M estimate. This represents a 5.23% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:50 pm

CPNG

Coupang, Inc. (NYSE:CPNG) reported Q4 results surpassing expectations with adjusted earnings of 8 cents per share against an estimate of 6 cents, and sales of $6.6 billion against an estimate of $6.44 billion. The company saw a 23.9% year-over-year sales increase and significant growth in its Product Commerce and Developing Offerings segments. CEO Bom Kim highlighted the growth in revenues, active customers, and WOW members, attributing it to the company's focus on customer satisfaction and value, especially through the WOW membership program.

Portfolio Pulse from Erica Kollmann

February 27, 2024 | 10:49 pm

MTUS

Metallus reported that its Q1 shipments are expected to be slightly lower than those in Q4 2023. This indicates a potential short-term decrease in operational output or sales.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:48 pm

OVV

Ovintiv (NYSE:OVV) reported Q4 2023 adjusted EPS of $2.35, surpassing the $1.95 estimate, and sales of $3.17B, exceeding the $2.72B estimate. This represents a 158.24% increase in EPS and a slight 1.43% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:48 pm

WMK

Weis Markets reported a decrease in both earnings per share (EPS) and sales for Q4, with EPS dropping to $0.76 from $1.07 year-over-year (YoY) and sales decreasing to $1.21 billion from $1.31 billion YoY.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:47 pm

CJJD

China Jo-Jo Drugstores announced a 1-for-20 reverse stock split, effective immediately. This action is typically taken to increase the market price of a company's shares, making them more appealing to investors and potentially in compliance with stock exchange listing requirements.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:41 pm

IMAX

IMAX anticipates its gross box office for 2024 to be similar to the figures reported in 2023, indicating a stable performance outlook for the company.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:40 pm

LMAT

LeMaitre Vascular forecasts Q1 EPS of $0.36-$0.41, surpassing the $0.34 estimate, with sales expected between $50.5M-$52.9M, also above the $50.21M estimate. For FY24, the company anticipates an EPS of $1.60-$1.71, exceeding the $1.53 estimate, and sales projections of $209.7M-$214.3M, slightly above the $209.99M estimate.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:39 pm

MASI

Masimo Corporation projects its Q1 2024 adjusted EPS to be between $0.67 and $0.74, compared to the estimated $0.73. The company also forecasts revenue to range from $476M to $501M, which is below the estimated $514.380M.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:36 pm

TMST

TimkenSteel (NYSE:TMST) reported Q4 2023 adjusted EPS of $0.36, surpassing the $0.27 estimate, and sales of $328.10M, exceeding the $326.97M estimate. This represents a significant improvement from the previous year, with a 460% increase in EPS and a 33.70% increase in sales.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:36 pm